Home β€Ί Stock analysis β€Ί NEO

Neogenomics (NEO) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

NEO rises 2.2% to $17.25, 3 up days in a row. Closed at $17.25, +2.19% vs the prior close of $16.88. Day range $16.61–$17.34, opened at $17.00.

Last close$17.25+2.19%
Day range16.61–17.34
Open17.00
Volume1.31M
52-week range7.07–20.15
Avg volume (20d)2.53M

NEO daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 β€” NEO rises 2.2% to $17.25, 3 up days in a row
Oct 14, 2026 β€” NEO rises 1.3% to $16.88
Oct 13, 2026 β€” NEO rises 2.8% to $16.66
Oct 12, 2026 β€” NEO dips 0.9% to $16.20
Oct 9, 2026 β€” NEO rises 2.1% to $16.35
Oct 8, 2026 β€” NEO rises 0.3% to $16.02
Oct 7, 2026 β€” NEO slides 3.3% to $15.97, a 1-month low
Oct 6, 2026 β€” NEO slides 13.7% to $16.51, a 1-month low on 2.3x normal volume
Oct 5, 2026 β€” NEO jumps 3.6% to $19.13
Oct 2, 2026 β€” NEO jumps 3.9% to $18.47

NEO latest news & SEC filings

Every SEC filing by or about NEO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 5, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001628280-26-064959

Oct 5, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001077183-26-000069

Sep 3, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001628280-26-060499

Aug 25, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001628280-26-058913

Aug 25, 2026 Β· Form S-8 β€” Employee share plan registration

Registration of shares for employee stock plans (S-8)

Source: SEC EDGAR filing 0001077183-26-000064

Aug 14, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001999371-26-018013

Aug 11, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001628280-26-055697

Aug 6, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001646370-26-000002

Aug 4, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001950047-26-007613

Jul 30, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001950047-26-007427

Jul 30, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0002012383-26-003193

Jul 30, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001445546-26-005565

Jul 28, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001077183-26-000059

Jul 28, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001077183-26-000058

Jul 22, 2026 Β· Form 8-K/A β€” Current report (amended)

Amended current report

Source: SEC EDGAR filing 0001077183-26-000049

Things to know before you trade NEO

NEO market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 202617.0017.3416.6117.251.31M
Oct 14, 202616.4917.2516.4516.881.62M
Oct 13, 202616.3016.9815.9816.662.23M
Oct 12, 202616.3516.3515.8616.201.18M
Oct 9, 202616.0216.6616.0016.351.39M
Oct 8, 202615.7216.0915.4116.023.52M
Oct 7, 202616.3616.6415.8815.973.19M
Oct 6, 202620.0020.1516.4716.515.10M
Oct 5, 202618.4819.1318.2819.132.05M
Oct 2, 202617.9918.6917.9418.472.30M
Oct 1, 202618.1818.7617.7417.782.47M
Sep 30, 202618.7618.9718.2818.362.47M
Sep 29, 202619.3019.7518.5818.742.70M
Sep 28, 202619.0219.5919.0119.291.30M
Sep 25, 202619.5619.7518.8719.332.02M
Sep 24, 202618.4719.7318.4019.562.95M
Sep 23, 202618.6919.0818.2718.362.91M
Sep 22, 202619.2819.6018.8318.894.00M
Sep 21, 202619.9220.0519.2819.411.44M
Sep 18, 202619.9120.0319.4019.914.40M

About Neogenomics

Neogenomics (NEO) is listed on the Nasdaq and classified by the SEC under β€œServices-Testing Laboratories”. Its business address is in FORT MYERS, FL. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1077183.

NEO board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Marjorie C GreenDirectorJun 3, 2026
Neil GunnDirectorJun 3, 2026
Stephen M KanovskyDirectorJun 3, 2026
Michael Aaron KellyDirectorJun 3, 2026
John P. KennyDirectorJun 3, 2026
David Brian PerezDirectorJun 3, 2026
Carolyn S StarrettDirectorJun 25, 2026
Lynn A. TetraultDirectorJun 17, 2026
Felicia WilliamsDirectorJun 3, 2026
Anthony P. ZookChief Executive OfficerApr 3, 2026

Executive officers

NameTitleLatest filing
Greg D AunanChief Accounting OfficerAug 6, 2026
Abhishek JainChief Financial OfficerMar 2, 2026
Alicia C OlivoEVP, GC & Business DevelopmentSep 3, 2026
Jeffrey Scott ShermanChief Financial OfficerFeb 24, 2026
Warren StonePres & Chief Operating OfficerAug 25, 2026
Anthony P. ZookChief Executive OfficerApr 3, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Aug 4, 2026Greg D AunanSale20,000$16.07
Jun 15, 2026Lynn A. TetraultSale5,307$11.10
Jun 9, 2026Lynn A. TetraultSale5,307$11.29
Jan 20, 2026Warren StoneSale22,128$12.50
Nov 25, 2025Alicia C OlivoSale20,916$12.00
Oct 16, 2025Alicia C OlivoSale4,918$10.00

NEO financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025β€”$-108.03Mβ€”$5.23M
Dec 31, 2024β€”$-78.73Mβ€”$7.02M
Dec 31, 2023β€”$-87.97Mβ€”$-1.95M
Dec 31, 2022β€”$-144.25Mβ€”$-65.99M
Dec 31, 2021β€”$-8.35Mβ€”$-26.72M

Latest balance sheet: total assets $1.35B, total liabilities $566.51M, cash $145.54M (as of Jun 30, 2026).

NEO earnings / results-day log

DateFilingClose that day
Oct 5, 20268-K Item 2.02 (results)$19.13
Jul 28, 20268-K Item 2.02 (results)$13.40
Apr 28, 20268-K Item 2.02 (results)$9.02
Feb 17, 20268-K Item 2.02 (results)$11.44
Jan 12, 20268-K Item 2.02 (results)$12.49
Oct 28, 20258-K Item 2.02 (results)$9.92
Jul 29, 20258-K Item 2.02 (results)$5.25
Apr 29, 20258-K Item 2.02 (results)$6.58
Feb 18, 20258-K Item 2.02 (results)$12.41
Nov 5, 20248-K Item 2.02 (results)$14.93
Jul 29, 20248-K Item 2.02 (results)β€”
Apr 30, 20248-K Item 2.02 (results)β€”

Related stocks Β· Services-Testing Laboratories

UL Solutions (ULS)20/20 Biolabs (AIDX)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on NEO

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.